ESSA Pharma Inc (NASDAQ:EPIX) (TSE:EPI) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $2.39 and traded as low as $2.28. ESSA Pharma shares last traded at $2.38, with a volume of 908 shares traded.
Several equities research analysts recently weighed in on the stock. Zacks Investment Research cut shares of ESSA Pharma from a “hold” rating to a “sell” rating in a research report on Thursday, May 16th. HC Wainwright restated a “buy” rating on shares of ESSA Pharma in a research report on Friday, May 17th.
The stock has a market capitalization of $14.39 million, a price-to-earnings ratio of -0.90 and a beta of 1.99. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.60.
About ESSA Pharma (NASDAQ:EPIX)
ESSA Pharma Inc, a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.